Bruker (NASDAQ:BRKR) Shares Up 3.9% – Here’s What Happened

Bruker Corporation (NASDAQ:BRKR) rose 3.9% during mid-day trading on Tuesday . The company traded as high as $54.99 and last traded at $54.7180. 291,047 shares changed hands during mid-day trading, a decline of 88% from the average daily volume of 2,341,848 shares. The stock had previously closed at $52.66.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on the stock. Leerink Partners lifted their target price on shares of Bruker from $60.00 to $70.00 and gave the stock an “outperform” rating in a research report on Tuesday, July 7th. TD Cowen restated a “hold” rating on shares of Bruker in a research report on Wednesday, July 15th. Stifel Nicolaus set a $50.00 price target on shares of Bruker in a research note on Wednesday, August 5th. UBS Group started coverage on shares of Bruker in a report on Wednesday, September 9th. They set a “neutral” rating and a $65.00 price target on the stock. Finally, Barclays boosted their price objective on shares of Bruker from $53.00 to $60.00 and gave the stock an “overweight” rating in a research note on Wednesday, June 24th. One equities research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating, five have assigned a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $57.00.

Bruker Stock Performance

The stock has a 50 day moving average of $58.09 and a 200 day moving average of $49.66. The company has a market capitalization of $9.24 billion, a price-to-earnings ratio of -86.67, a price-to-earnings-growth ratio of 1.71 and a beta of 1.26. The company has a quick ratio of 0.92, a current ratio of 1.85 and a debt-to-equity ratio of 0.76.

Bruker (NASDAQ:BRKR) last released its earnings results on Tuesday, August 4th. The medical research company reported $0.49 earnings per share for the quarter, beating analysts’ consensus estimates of $0.38 by $0.11. Bruker had a negative net margin of 2.35% and a positive return on equity of 12.47%. The business had revenue of $838.50 million during the quarter, compared to the consensus estimate of $853.57 million. During the same quarter in the prior year, the firm posted $0.32 EPS. The company’s revenue for the quarter was up 5.2% compared to the same quarter last year. Bruker has set its FY 2026 guidance at 2.100-2.150 EPS. As a group, analysts predict that Bruker Corporation will post 2.12 EPS for the current year.

Bruker Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 7th. Stockholders of record on Monday, September 21st will be given a dividend of $0.05 per share. The ex-dividend date is Monday, September 21st. This represents a $0.20 annualized dividend and a dividend yield of 0.3%. Bruker’s dividend payout ratio is -28.57%.

Insider Buying and Selling at Bruker

In related news, VP Mark Munch sold 2,000 shares of Bruker stock in a transaction on Tuesday, September 15th. The shares were sold at an average price of $52.87, for a total transaction of $105,740.00. Following the completion of the transaction, the vice president owned 134,806 shares of the company’s stock, valued at $7,127,193.22. This trade represents a 1.46% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 27.20% of the stock is currently owned by company insiders.

Institutional Trading of Bruker

A number of large investors have recently bought and sold shares of the business. Essential Partners LLC acquired a new position in shares of Bruker in the 1st quarter valued at about $36,000. Global Retirement Partners LLC acquired a new stake in Bruker during the second quarter worth approximately $38,000. EverSource Wealth Advisors LLC increased its holdings in Bruker by 532.9% in the first quarter. EverSource Wealth Advisors LLC now owns 1,500 shares of the medical research company’s stock worth $54,000 after purchasing an additional 1,263 shares in the last quarter. FNY Investment Advisers LLC bought a new stake in Bruker in the second quarter worth approximately $60,000. Finally, IFP Advisors Inc lifted its stake in Bruker by 88.6% in the second quarter. IFP Advisors Inc now owns 1,060 shares of the medical research company’s stock valued at $64,000 after buying an additional 498 shares during the period. 79.52% of the stock is currently owned by institutional investors and hedge funds.

About Bruker

Bruker Corporation develops and manufactures scientific instruments, analytical systems and software used to study the chemical, physical and biological properties of materials. Its customers include universities, pharmaceutical and biotechnology companies, industrial manufacturers, hospitals, government laboratories and other research organizations.

The company’s product portfolio includes nuclear magnetic resonance and electron paramagnetic resonance systems, mass spectrometers, X-ray analysis instruments, optical and molecular spectroscopy systems, microscopy and nanoanalysis tools, and instruments for microbiology and spatial biology.